|
1
|
Egawa S, Toma H, Ohigashi H, Okusaka T,
Nakano A, Hatori T, Maguchi H, Yanagisawa A and Tanaka M: Japan
pancreatic cancer registry; 30th year anniversary: Japan pancreas
society. Pancreas. 41:985–992. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Verma V, Li J and Lin C: Neoadjuvant
therapy for pancreatic cancer: Systematic review of postoperative
morbidity, mortality, and complications. Am J Clin Oncol.
39:302–313. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Uesaka K, Boku N, Fukutomi A, Okamura Y,
Konishi M, Matsumoto I, Kaneoka Y, Shimizu Y, Nakamori S, Sakamoto
H, et al: Adjuvant chemotherapy of S-1 versus gemcitabine for
resected pancreatic cancer: A phase 3, open-label, randomised,
non-inferiority trial (JASPAC 01). Lancet. 388:248–257. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Farrugia A: Albumin usage in clinical
medicine: Tradition or therapeutic? Transfus Med Rev. 24:53–63.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gabay C and Kushner I: Acute-phase
proteins and other systemic responses to inflammation. N Eng J Med.
340:448–454. 1999. View Article : Google Scholar
|
|
7
|
Namendys-Silva SA, Gonzalez-Herrera MO,
Texcocano-Becerra J and Herrera-Gomez A: Hypoalbuminemia in
critically ill patients with cancer: Incidence and mortality. Am J
Hosp Palliat Care. 28:253–257. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fuhrman MP: The albumin-nutrition
connection: Separating myth from fact. Nutrition. 18:199–200. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Visser M, Kritchevsky SB, Newman AB,
Goodpaster BH, Tylavsky FA, Nevitt MC and Harris TB: Lower serum
albumin concentration and change in muscle mass: The health, aging
and body composition study. Am J Clin Nutr. 82:531–537. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Haruki K, Shiba H, Shirai Y, Horiuchi T,
Iwase R, Fujiwara Y, Furukawa K, Misawa T and Yanaga K: The
C-reactive protein to albumin ratio predicts long-term outcomes in
patients with pancreatic cancer after pancreatic resection. World J
Surg. 40:2254–2260. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kanda M, Fujii T, Kodera Y, Nagai S,
Takeda S and Nakao A: Nutritional predictors of postoperative
outcome in pancreatic cancer. Br J Surg. 98:268–274. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Imaoka H, Mizuno N, Hara K, Hijioka M,
Tajika M, Tanaka T, Ishihara M, Yogi T, Tsutsumi H, Fujiyoshi T, et
al: Evaluation of modified glasgow prognostic score for pancreatic
cancer: A retrospective cohort study. Pancreas. 45:211–217. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nakano Y, Kitago M, Matsuda S, Nakamura Y,
Fujita Y, Imai S, Shinoda M, Yagi H, Abe Y, Hibi T, et al: KRAS
mutations in cell-free DNA from preoperative and postoperative sera
as a pancreatic cancer marker: A retrospective study. Br J Cancer.
118:662–669. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nakano Y, Kitago M, Shinoda M, Abe Y, Yagi
H, Hibi T, Takeuchi A, Aiura K, Itano O and Kitagawa Y: Clinical
predictive factors of long-term survival after curative resection
of pancreatic cancer: A retrospective study. Br J Cancer.
6:2278–2281. 2018.
|
|
15
|
Fujii-Nishimura Y, Nishiyama R, Kitago M,
Masugi Y, Ueno A, Aiura K, Kawachi S, Kawaida M, Abe Y, Shinoda M,
et al: Two cases of pathological complete response to neoadjuvant
chemoradiation therapy in pancreatic cancer. Keio J Med. 64:26–31.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Japan Pancreas Society: Classification of
pancreatic carcinoma. 2nd English ed. Tokyo. Kanehara2009.
|
|
17
|
Takahashi S, Aiura K, Saitoh J, Hayatsu S,
Kitajima M and Ogata Y: Treatment strategy for pancreatic head
cancer: Pylorus-preserving pancreatoduodenectomy, intraoperative
radiotherapy and portal catheterization. Digestion. 60
(Suppl):S130–S134. 1999. View Article : Google Scholar
|
|
18
|
Aiura K, Takahashi S, Matsui J, Ueda M and
Kitagawa Y: Beneficial effects of 5-Fluorouracil and heparin-based
portal infusion chemotherapy combined with mitomycin C and
cisplatin after curative resection of pancreatic cancer.
Pancreatology. 10:250–258. 2017. View Article : Google Scholar
|
|
19
|
McMillan DC, Watson WS, O'Gorman P, Tom
Preston, Scott HR and McArdle CS: Albumin concentrations are
primarily determined by the body cell mass and the systemic
inflammatory response in cancer patients with weight loss. Nutr
Cancer. 39:210–213. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schmid I, Schmitt M, Streiter M, Meilbeck
R, Haas RJ and Stachel DK: Effects of soluble TNF receptor II
(sTNF-RII), IL-1 receptor antagonist (IL-1ra), tumor load and
hypermetabolism on malnutrition in children with acute leukemia.
Eur J Med Res. 10:457–461. 2005.PubMed/NCBI
|
|
21
|
Matsuda S, Niihara M, Tsubosa Y, Sato H,
Takebayashi K, Kawamorita K, Mori K, Tsushima T, Yasui H, Takeuchi
H and Kitagawa Y: Clinical significance of postoperative recovery
of serum albumin levels in patients with esophageal cancer who
underwent transthoracic esophagectomy. Surg Today. 46:1138–1145.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ravasco P, Monteiro-Grillo I, Vidal PM and
Camilo ME: Dietary counseling improves patient outcomes: A
prospective, randomized, controlled trial in colorectal cancer
patients undergoing radiotherapy. J Clin Oncol. 23:1431–1438. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Roxburgh CSD, Crozier JEM, Maxwell F,
Foulis AK, Brown J, McKee RF, Anderson JH, Horgan PG and McMillan
DC: Comparison of tumour based (Petersen Index) and
inflammation-based (Glasgow Prognostic Score) scoring systems in
patients undergoing curative resection for colon cancer. Br J
Cancer. 100:701–706. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
McMillan DC, Crozier JE, Canna K, Angerson
WJ and McArdle CS: Evaluation of an inflammation based prognostic
score (GPS) in patients undergoing resection for colon and rectal
cancer. Int J Colorectal Dis. 22:881–886. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gilliland TM, Villafane-Ferriol N, Shah
KP, Shah RM, Tran Cao HS, Massarweh NN, Silberfein EJ, Choi EA, Hsu
C and McElhany CA: Nutritional and metabolic derangements in
pancreatic cancer and pancreatic resection. Nutrients. 9:E2432017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shu XL, Kang K, Gu LJ and Zhang YS: Effect
of early enteral nutrition on patients with digestive tract
surgery: A meta-analysis of randomized controlled trials. Exp Ther
Med. 12:2136–2144. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Okada S, Yamazaki S, Kaiga T, Funada T,
Kochi M and Takayama T: Impact of nutritional status in the era of
FOLFOX/FIRI-based chemotherapy. World J Surg Oncol. 15:162–169.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Conroy T, Hammel P, Hebbar M, Ben
Abdelghani M, Wei AC, Raoul JL, Chone L, Francois E, Artru A, Biagi
JJ, et al: Folfirinox or gemcitabine as adjuvant therapy for
pancreatic cancer. N Engl J Med. 379:2395–2406. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fleck A, Raines G, Hawker F, Trotter J,
Wallace PI, Ledingham IM and Calman KC: Increased vascular
permeability: A major cause of hypoalbuminaemia in disease and
injury. Lancet. 1:781–784. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hubner M, Mantziari S, Demartines N,
Pralong F, Coti-Bertrand P and Schafer M: Postoperative albumin
drop is a marker for surgical stress and a predictor for clinical
outcome: A pilot study. Gastroenterol Res Pract.
87431872016.PubMed/NCBI
|
|
31
|
Gao Q, Mok HP, Wang WP, Xiao F and Chen
LQ: Effect of perioperative glucocorticoid administration on
postoperative complications following esophagectomy: A
meta-analysis. Oncol Lett. 7:349–356. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Takata A, Takiguchi S, Miyazaki Y, Miyata
H, Takahashi T, Kurokawa Y, Yamasaki M, Nakajima K, Mori M,
Kanagawa K and Doki Y: Randomized phase II study of the
anti-inflammatory effect of ghrelin during the postoperative period
of esophagectomy. Ann Surg. 262:230–236. 2015. View Article : Google Scholar : PubMed/NCBI
|
